Patient and Expert Engagement
1. Insights Generation
Situation
Bringing deep insights from external stakeholders is critical to maximise the potential of pharmacological and non-pharmacological interventions for patients and those who care for them.
Irrespective of lifecycle stage, from early to late stage development, with HCP or patient communities, we have the skill-set needed to design, develop and deliver in line with your needs. Whether you require input into key development decisions, a better understanding of the evolving treatment landscape, evaluation of clinical data, expertise to co-design educational content or test key messages, we will generate the required insights. This may be a standalone activity or equally establishing a working group for engagement over a longer time period.
What happens
We will partner with you to:
1. Understand your objectives and help to define key questions
2. Define and design the best approach based on your goals and target group(s)
3. Identify and facilitate engagement of advisors
4. Design the engagement plan to guarantee productive interactions
5. Facilitate interactions to guide discussions
6. Create report with actionable insights
Expected Outcome
Timely, insightful, actionable advice and insights from the patient and / or healthcare expert community, giving you the confidence to make informed decisions, progress your plans or simply co-develop your disease awareness and educational materials
2. Advancing Medical practice through Strategic Partnerships
Situation
As part of your annual planning cycle or at any point in the development of your asset/disease portfolio, being thoughtful as to your short, medium and long term approach to external collaborations is critical. Collaborations and partnerships with other stakeholders broadens the scope of what can be achieved for your patient community. As Biopharma you may act as a sponsor, a partner in a broader collaboration with disease consortia, patient advocacy organisations, professional societies or indeed work alongside other Biopharma companies. If you are about to embark on this as part of your planning, whether it’s to build an initial plan or refresh an existing one, we can help.
What happens
We will partner with you to:
1. Review individual asset and / or multiple asset strategies in a given disease area, to identify synergies
2. Collate a landscape view on existing external investments – scope, costs, timing, and expected outcomes
3. Bench exercise to understand and map shared strategic priorities and potential opportunities for collaboration
4. Where required, development of a single disease/asset narrative to support you in articulating priorities and opening discussions for collaborative opportunities
Expected Outcome
Development of a 3-5 year fully costed external investment plan based on one or more asset strategies within a disease area, with associated lead and lag impact measures. If required, a core communication plan to support delivery of your engagement strategy
3. Understanding and communicating patient lived-experience
Situation
Listening to and learning from the patients living with or at risk of that condition brings invaluable unexpected insights to inform your Medical and Scientific Communications plans. Furthermore, these compelling patient stories can be re-produced for Healthcare Professional and Patient education purposes; ideal for use at scientific congresses, as social media posts, on your website, as email content and / or to enhance engagement by MSLs by bringing the necessary clinical and patient context to scientific data
What happens
1. Engagement of External Experts and Patient Organisations to identify and connect with patients willing to share their lived experiences
2. Engagement of patients representing different communities around the world sharing those lived experiences
3. Creation of a ‘Patient Diary Series’ comprising of written, spoken or video accounts from patients and caregivers
4. Development of actionable insights reports
5. Partnership with award winning creative agency to develop educational content tailored for priority channels